🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Dasatinib - Medicines in Ireland

33 authorised products containing Dasatinib, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 33 authorised medicines
MedicineActive substanceLicence holderStatus
Dasatinib Accord Healthcare 100 mg film-coated tablets
EU/1/24/1839/017-020
Dasatinib Accord Healthcare S.L.U.
Dasatinib Accord Healthcare 140 mg film-coated tablets
EU/1/24/1839/021-024
Dasatinib Accord Healthcare S.L.U.
Dasatinib Accord Healthcare 20 mg film-coated tablets
EU/1/24/1839/001-004
Dasatinib Accord Healthcare S.L.U.
Dasatinib Accord Healthcare 50 mg film-coated tablet
EU/1/24/1839/005-008
Dasatinib Accord Healthcare S.L.U.
Dasatinib Accord Healthcare 70 mg film-coated tablets
EU/1/24/1839/009-012
Dasatinib Accord Healthcare S.L.U.
Dasatinib Accord Healthcare 80 mg film-coated tablets
EU/1/24/1839/013-016
Dasatinib Accord Healthcare S.L.U.
Dasatinib Clonmel 100 mg film-coated tablets
PA0126/310/004
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Clonmel 20 mg film-coated tablets
PA0126/310/001
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Clonmel 50 mg film-coated tablets
PA0126/310/002
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Clonmel 70 mg film-coated tablets
PA0126/310/003
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Krka 100 mg film-coated tablets
PA1347/093/005
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 140 mg film-coated tablets
PA1347/093/006
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 20 mg film-coated tablets
PA1347/093/001
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 50 mg film-coated tablets
PA1347/093/002
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 70 mg film-coated tablets
PA1347/093/003
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 80 mg film-coated tablets
PA1347/093/004
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Teva 100 mg Film-coated Tablets
PA1986/066/004
Dasatinib Teva B.V. Marketed
Dasatinib Teva 20 mg Film-coated Tablets
PA1986/066/001
Dasatinib Teva B.V. Marketed
Dasatinib Teva 50 mg Film-coated Tablets
PA1986/066/002
Dasatinib Teva B.V. Marketed
Dasatinib Teva 70 mg Film-coated Tablets
PA1986/066/003
Dasatinib Teva B.V. Marketed
Mubucho 111 mg film-coated tablets
PA1701/003/006
Dasatinib Zentiva k.s. Not marketed
Mubucho 16 mg film-coated tablets
PA1701/003/001
Dasatinib Zentiva k.s. Marketed
Mubucho 40 mg film-coated tablets
PA1701/003/002
Dasatinib Zentiva k.s. Marketed
Mubucho 55 mg film-coated tablets
PA1701/003/003
Dasatinib Zentiva k.s. Marketed
Mubucho 63 mg film-coated tablets
PA1701/003/004
Dasatinib Zentiva k.s. Not marketed
Mubucho 79 mg film-coated tablets
PA1701/003/005
Dasatinib Zentiva k.s. Marketed
Sprycel 10 mg/mL powder for oral suspension
EU/1/06/363/016
Dasatinib Bristol-Myers Squibb Pharma EEIG
Sprycel 100 mg film-coated tablets
EU/1/06/363/010-11
Dasatinib Bristol-Myers Squibb Pharma EEIG
Sprycel 140 mg film-coated tablets
EU/1/06/363/014-015
Dasatinib Bristol-Myers Squibb Pharma EEIG
Sprycel 20 mg film-coated tablets
EU/1/06/363/1-4-7
Dasatinib Bristol-Myers Squibb Pharma EEIG
Sprycel 50 mg film-coated tablet
EU/1/06/363/2-5-8
Dasatinib Bristol-Myers Squibb Pharma EEIG
Sprycel 70 mg film-coated tablets
EU/1/06/363/3-6-9
Dasatinib Bristol-Myers Squibb Pharma EEIG
Sprycel 80 mg film-coated tablets
EU/1/06/363/012-013
Dasatinib Bristol-Myers Squibb Pharma EEIG
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.